FIELD: medicine, pharmaceutics.
SUBSTANCE: presented group of inventions refers to medicine and veterinary science. What is presented is a biocomposite for performing reparative processes following an injury in a mammal, containing a carrier, at least one nucleic acid containing genes coding VEGF and/or SDF-1, and cells ensuring reparative regeneration. There are presented methods for preparing the above biocomposite and a kit for preparing the same. There are also presented a method for providing injury healing in a mammal and a method for delivering nucleic acid.
EFFECT: presented group of inventions provides effective tissue regeneration following the injury in the mammal by using the three-component biocomposite consisting of the carrier, at least one nucleic acid and the cells ensuring reparative regeneration.
16 cl, 4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD TO OBTAIN OPTIMIZED SOLID GENE-ACTIVATED MATERIAL, METHOD TO OBTAIN SOLID CARRIER MATRIX, OPTIMIZED SOLID GENE-ACTIVATED MATERIAL FOR TISSUE REGENERATION | 2016 |
|
RU2623171C1 |
CODON-OPTIMISED SEQUENCES AND PHARMACEUTICAL COMPOSITION FOR RECOVERY OF BLOOD VESSELS | 2014 |
|
RU2557385C1 |
METHOD FOR REPARATIVE ANGIOGENESIS STIMULATION AND CONNECTIVE TISSUE REGENERATION IN CASE OF ITS DAMAGE, BY THE GENETIC THERAPY METHOD USING SPECIES-SPECIFIC VEGF AND FGF2 PROTEIN FACTORS GENES IN VETERINARY MEDICINE, AND GENETIC STRUCTURE FOR IMPLEMENTATION OF METHOD | 2015 |
|
RU2614665C1 |
CARRIER FOR TARGETED DELIVERY OF NUCLEIC ACIDS TO CELLS EXPRESSING RECEPTOR CXCR4 | 2012 |
|
RU2522810C1 |
METHOD FOR DIRECTED DELIVERY OF DNA INTO TUMOR AND STEM CELLS | 2008 |
|
RU2408607C2 |
IMMUNOLOGICALLY PRIVILEGED BIOACTIVE KIDNEY CELLS FOR TREATMENT OF KIDNEY DISEASE | 2018 |
|
RU2816753C2 |
METHOD FOR PREPARING PLURIPOTENT CELLS | 2009 |
|
RU2399667C1 |
METHOD FOR CREATING PERSONALIZED GENE-ACTIVATED IMPLANT FOR BONE TISSUE REGENERATION | 2015 |
|
RU2597786C2 |
METHOD OF OBTAINING BIO COMPOSITE EX TEMPORE AND METHOD OF BIO SINUS LIFTING USING OBTAINED BIO COMPOSITE | 2023 |
|
RU2808883C1 |
METHOD OF PROVIDING SAFETY OF APPLICATION OF PLURIPOTENT STEM CELLS IN TISSUE-SUBSTITUTING THERAPY BY MEANS OF ARTIFICIAL CHROMOSOMES | 2012 |
|
RU2548819C2 |
Authors
Dates
2014-06-10—Published
2011-12-29—Filed